CHGCF News and Press, Chugai Pharmaceutical

2024-04-24 23:40:02 ET Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Conference Call April 24, 2024 5:00 AM ET Company Participants Kae Miyata - Head of Corporate Communications Osamu Okuda - President and Chief Executive Officer Tsukasa Kusano - Execu...

2024-03-21 07:00:09 ET More on Argenx SE argenx SE (ARGX) Q4 2023 Earnings Call Transcript argenx: Upgrading To 'Strong Buy' On Vyvgart's Q4 Sales, Empasiprubart Data, Pipeline Expansion Argenx SE GAAP EPS of -$1.68 misses by $0.30, revenue of $374M beats by $10.28M ...

2024-02-18 02:05:00 ET Summary LianBio plans to stop all its operations by the end of 2024 and will distribute a $4.80 dividend/share ($528M) to its shareholders. Yiviva signed a memorandum of understanding with AstraZeneca China for an R&D collaboration at AstraZeneca’...

2024-01-29 13:32:25 ET More on iShares MSCI ACWI ETF: ACWI: A Stellar End To 2023, Eyeing Early 2024 Election Year Risks Global economic growth set to weaken further this year, World Bank says Top Global Triple Momentum stocks - BofA Securities Seeking Alpha&...

2023-12-17 02:00:00 ET Summary SystImmune out-licenses global rights for a bispecific ADC to Bristol Myers Squibb in an $8.4 billion agreement. Evive Biotech forms an antibody discovery collaboration with Nona Biosciences to accelerate the process of antibody discovery and drug de...

2023-10-24 09:48:26 ET More on Chugai Pharmaceutical Historical earnings data for Chugai Pharmaceutical Dividend scorecard for Chugai Pharmaceutical Financial information for Chugai Pharmaceutical For further details see: Chugai Pharmaceutical GAAP EPS of...

2023-07-27 17:44:28 ET Chugai Pharmaceutical press release ( OTCPK:CHGCF ): 1H GAAP EPS of ¥95.23. Revenue of ¥579.66B (-2.7% Y/Y). For further details see: Chugai Pharmaceutical GAAP EPS of ¥95.23, revenue of ¥579.66B

Chugai Pharmaceutical ( OTCPK:CHGCF ) ( OTCPK:CHGCY ) and Biofourmis signed a new collaboration agreement for the continued development and real-world use of digital solutions to measure pain in patients with endometriosis. Endometriosis is a condition in which cells similar to&#...

Chugai Pharmaceutical press release ( OTCPK:CHGCF ): FY GAAP EPS of ¥227.57. Revenue of ¥1.26B. For further details see: Chugai Pharmaceutical GAAP EPS of ¥227.57, revenue of ¥1.26B

Chugai Pharmaceutical press release ( OTCPK:CHGCF ): 9M GAAP EPS of ¥165.29. Revenue of ¥821.45B (+21.2% Y/Y). For further details see: Chugai Pharmaceutical reports 9M results